Dokkyo Medical University · Faculty of Medicine

Research keywordsOncology・Immunotherapy・日・Pembrolizumab・medicine・丸山・Internal・Lymphocyte

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• オリゴ転移尿路上皮癌の転移巣に対する放射線治療の治療成績, 丸山 理子;三谷 康輝;倉科 凌;井上 雅晴;松岡 陽;坂本 宗一郎;松井 利晃;村田 裕人;島野 靖正;牛島 弘毅;工藤 滋弘;影山 幸雄, 埼玉県医学会雑誌, 58（1）, np48, 2024年01月2024 · 論文
• Increased expression of ATP-binding cassette transporters in enfortumab vedotin-resistant urothelial cancer., Kotono Mariko;Kijima Toshiki;Takada-Owada Atsuko;Okubo Naoya;Kurashina Ryo;Kokubun Hidetoshi;Uematsu Toshitaka;Takei Kohei;Ishida Kazuyuki;Kamai Takao, IJU case reports, 7（2）, 173-176, 2024年01月29日2024 · 論文
• Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma., Ando Kiyohiro;Kurashina Ryo;Motoi Noriko;Iizuka Toshihiko;Inoue Masaharu;Maruyama Riko;Mitani Kouki;Takenobu Hisanori;Haruta Masayuki;Onuki Ritsuko;Matsuoka Yoh;Kamijo Takehiko;Kageyama Yukio, Biochemical and biophysical research communications, 676, 165-170, 2023年07月26日2023 · 論文
• A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab., Kokubun Hidetoshi;Kijima Toshiki;Takada-Owada Atsuko;Mamiya Daisuke;Kurashina Ryo;Okubo Naoya;Uematsu Toshitaka;Takei Kohei;Ishida Kazuyuki;Kamai Takao, IJU case reports, 6（6）, 440-444, 2023年09月14日2023 · 論文

• Official profile